Replimune director proposes $113K share sale
The notice says the shares were acquired from the issuer through exercise on July 20, 2018, with cash listed as payment.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Replimune Group, Inc. (REPL) lists a proposed sale by its director, Joseph P. Slattery, of 5,200 common shares, with an aggregate market value of $113,360. The approximate sale date is November 9, 2026, and Morgan Stanley Smith Barney LLC is listed as broker.
Key Figures
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.